Improved survival in 211 patients with stage IV carcinoid tumor treated with high dose I-131 MIBG is predicted by response at initial follow up and by multiple rounds of I-131 MIBG.

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.